Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma
Paulette Mhawech‐Fauceglia, Shashikant Lele(Memorial Sloan Kettering Cancer Center), Tanja Pejović(Oregon Health & Science University), Song Liu(Qingdao University), Dan Wang(Tianjin University of Traditional Chinese Medicine), Faith Ough(University of Southern California), Heidi Godoy(Roswell Park Comprehensive Cancer Center), Damanzoopinder Samrao(University of Southern California)
Cited by 25
Related Papers
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Tumor-infiltrating NY-ESO-1–specific CD8 <sup>+</sup> T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
|Proceedings of the National Academy of Sciences|2010|844
Tumor Necrosis Factor α-induced Phosphorylation of RelA/p65 on Ser529 Is Controlled by Casein Kinase II
|Journal of Biological Chemistry|2000|450
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
|The Lancet Oncology|2013|434
Activation of Nuclear Factor-κB-dependent Transcription by Tumor Necrosis Factor-α Is Mediated through Phosphorylation of RelA/p65 on Serine 529
|Journal of Biological Chemistry|1998|379